Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Oligodendroglioma”

280 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 280 results

Testing effectiveness (Phase 2)Study completedNCT00007982
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

Who this might be right for
Brain and Central Nervous System TumorsHead and Neck CancerLymphoma
Herbert Irving Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00058123
What this trial is testing

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Testing effectiveness (Phase 2)Study completedNCT00404248
What this trial is testing

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Early research (Phase 1)Ended earlyNCT01378481
What this trial is testing

High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00087061
What this trial is testing

Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00730613
What this trial is testing

Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
City of Hope Medical Center 3
Testing effectiveness (Phase 2)Study completedNCT01462695
What this trial is testing

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Who this might be right for
Childhood Cerebellar Anaplastic AstrocytomaChildhood Cerebral Anaplastic AstrocytomaChildhood Cerebral Astrocytoma+8 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00979173
What this trial is testing

Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma

Who this might be right for
Glioma
Annick Desjardins 5
Testing effectiveness (Phase 2)Study completedNCT03027388
What this trial is testing

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grades II, III and IVGlioblastoma MultiformeGiant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT00004212
What this trial is testing

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Daiichi Sankyo
Early research (Phase 1)Active Not RecruitingNCT06254326
What this trial is testing

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

Who this might be right for
Recurrent OligodendrogliomaProgressive Oligodendroglioma
University of Florida 12
Early research (Phase 1)Study completedNCT01144247
What this trial is testing

Cellular Immunotherapy Study for Brain Cancer

Who this might be right for
GliomasAnaplastic AstrocytomaAnaplastic Oligodendroglioma+3 more
Jonsson Comprehensive Cancer Center 10
Early research (Phase 1)Study completedNCT02015819
What this trial is testing

Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
City of Hope Medical Center 16
Early research (Phase 1)WithdrawnNCT02055196
What this trial is testing

Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00045110
What this trial is testing

Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+6 more
National Cancer Institute (NCI) 136
Testing effectiveness (Phase 2)Study completedNCT00238264
What this trial is testing

Radiation Therapy in Treating Young Patients With Gliomas

Who this might be right for
Brain TumorCentral Nervous System Tumor
Children's Oncology Group 92
Testing effectiveness (Phase 2)Ended earlyNCT05297864
What this trial is testing

PARP Inhibition for Gliomas (PI-4G or π4g)

Who this might be right for
Recurrent GlioblastomaRecurrent AstrocytomaRecurrent Oligodendroglioma+1 more
University of Oklahoma 15
Early research (Phase 1)Study completedNCT00003484
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Darell D. Bigner, MD, PhD 21
Testing effectiveness (Phase 2)Study completedNCT00795665
What this trial is testing

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Who this might be right for
Glioma
University of California, Davis 7
Load More Results